Skin test performed with highly purified Mycobacterium tuberculosis recombinant protein triggers tuberculin shock in infected guinea pigs

被引:9
作者
Reece, ST
Stride, N
Ovendale, P
Reed, SG
Campos-Neto, A
机构
[1] Infect Dis Res Inst, Seattle, WA USA
[2] Corixa Corp, Seattle, WA USA
关键词
D O I
10.1128/IAI.73.6.3301-3306.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculin shock due to inoculation of Mycobacterium tuberculosis antigens in patients with tuberculosis is a serious syndrome originally described over 100 years ago by Robert Koch. Here, we present experimental evidence that a single M. tuberculosis recombinant protein, CFP-10, triggers this syndrome. Intradermal inoculation of CFP-10 elicits in M. tuberculosis-infected mice high levels of serum tumor necrosis factor alpha and causes tuberculin shock in infected guinea pigs characterized by hypothermia and death within 6 to 48 h after the antigen inoculation. Autopsies of these animals revealed intense polycythemia and hemorrhagic patches in the lung parenchyma, a pathological observation consistent with tuberculin shock. These results point to the possible occurrence of tuberculin shock in sensitive individuals inoculated with highly purified M. tuberculosis recombinant proteins as vaccine candidates or skin test reagents.
引用
收藏
页码:3301 / 3306
页数:6
相关论文
共 27 条
[1]  
*AM THOR SOC, 1981, AM REV RESPIR DIS, V124, P356
[2]  
American Thoracic Society, 1991, AM REV RESPIR DIS, V142, P725
[3]   A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10) [J].
Berthet, FX ;
Rasmussen, PB ;
Rosenkrands, I ;
Andersen, P ;
Gicquel, B .
MICROBIOLOGY-UK, 1998, 144 :3195-3203
[4]  
BEUTLER BA, 1985, J IMMUNOL, V135, P3972
[5]   RELATIONSHIP BETWEEN BACILLE CALMETTE-GUERIN (BCG) STRAINS AND THE EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS [J].
BREWER, TF ;
COLDITZ, GA .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) :126-135
[6]   OF POSTULATES AND PECCADILLOES - ROBERT KOCH AND VACCINE (TUBERCULIN) THERAPY FOR TUBERCULOSIS [J].
BURKE, DS .
VACCINE, 1993, 11 (08) :795-804
[7]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[8]   Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity [J].
Coler, RN ;
Skeiky, YAW ;
Ovendale, PJ ;
Vedvick, TS ;
Gervassi, L ;
Guderian, J ;
Jen, S ;
Reed, SG ;
Campos-Neto, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :224-233
[9]   Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG [J].
Dillon, DC ;
Alderson, MR ;
Day, CH ;
Bement, T ;
Campos-Neto, A ;
Skeiky, YAW ;
Vedvick, T ;
Badaro, R ;
Reed, SG ;
Houghton, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3285-3290
[10]   Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family [J].
Dillon, DC ;
Alderson, MR ;
Day, CH ;
Lewinsohn, DM ;
Coler, R ;
Bement, T ;
Campos-Neto, A ;
Skeiky, YAW ;
Orme, IM ;
Roberts, A ;
Steen, S ;
Dalemans, W ;
Badaro, R ;
Reed, SG .
INFECTION AND IMMUNITY, 1999, 67 (06) :2941-2950